HOUSTON--(BUSINESS WIRE)--Bellicum Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing novel cellular immunotherapies, today announced the appointment of Reid M. Huber, Ph.D. to its Board of Directors.
Dr. Huber has over 16 years of experience in pharmaceutical research and clinical development, in both senior leadership and scientific research positions. He currently serves as Executive Vice President and Chief Scientific Officer at Incyte Corporation where he leads drug discovery research primarily in the area of hematology/oncology.
Help employers find you! Check out all the jobs and post your resume.
Dr. Huber has over 16 years of experience in pharmaceutical research and clinical development, in both senior leadership and scientific research positions. He currently serves as Executive Vice President and Chief Scientific Officer at Incyte Corporation where he leads drug discovery research primarily in the area of hematology/oncology.
Help employers find you! Check out all the jobs and post your resume.
